Associations of Thrombocytopenia and Subthreshold Platelet Counts with Clinical Outcomes in Intensive Care Patients: A Prospective Cohort Study
- 1Division of Intensive Care Unit, Department of Internal Medicine, Kayseri City Education and Research Hospital, 38020 Kayseri, Türkiye
- 2Department of Internal Medicine, Kayseri City Education and Research Hospital, 38020 Kayseri, Türkiye
- 3Division of Hematology, Department of Internal Medicine, Kayseri City Education and Research Hospital, 38020 Kayseri, Türkiye
Abstract
Background/Objectives: Thrombocytopenia (TP) is common in critically ill patients, but the significance of its severity, timing, persistence, and admission subthreshold platelet count (PC) remains uncertain. We evaluated these associations with mortality in a medical ICU. Methods: In this prospective cohort study, 280 adults admitted to a tertiary medical ICU (September 2023–August 2024) were followed until ICU discharge or death. TP was defined as a PC < 150 × 109/L, and admission STP as a first ICU PC of 150–199 × 109/L, irrespective of later platelet course. Outcomes included mortality (ICU, hospital, 28-day, 90-day), organ support, and major complications. Results: TP occurred in 118 patients (42.1%), with higher crude mortality at all time points (all p < 0.001). In the lagged time-dependent Cox analysis, ICU-acquired TP was associated with ICU mortality in the minimally adjusted model (HR 1.93, CI 1.12–3.35; p = 0.018) but not after adjustment for invasive MV (aHR 1.31, CI 0.72–2.40; p = 0.372). Admission TP was not significantly associated with ICU mortality in the adjusted model (aHR 1.22, CI 0.74–2.00; p = 0.436). Admission PC showed limited discrimination (AUC 0.583, CI 0.508–0.657). No statistically significant difference was found between admission STP and PC ≥ 200 × 109/L (exploratory comparison, wide CIs). Conclusions: TP was associated with disease severity and worse crude outcomes, but adjusted longitudinal analyses did not establish an independent association with ICU mortality. No statistically significant difference was found for admission STP versus PC ≥ 200 × 109/L in this exploratory comparison; this should not be interpreted as clinical equivalence or as indicating no prognostic value.
Related
- A prospective study on the prevalence of neonatal alloimmune thrombocytopenia with maternal and neonatal human platelet antigen genotypic profiling.
- Sustained Platelet Improvement Temporally Associated with Dupilumab in Chronic Immune Thrombocytopenia: A Case Study
- RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies Initially Diagnosed as Immune Thrombocytopenia and Reclassified After 10 Years: Diagnostic Pitfall Revealed by a Family History
- Platelet trajectory subphenotypes in intensive care patients with sepsis-induced coagulopathy
- Molecular overlap between primary immune thrombocytopenia and inherited platelet disorders: A pediatric case report with a novel heterozygous ITGB3 variant identified by next-generation sequencing
BibTeX
@article{deveci2026associations,
title = {{Associations of Thrombocytopenia and Subthreshold Platelet Counts with Clinical Outcomes in Intensive Care Patients: A Prospective Cohort Study}},
author = {Kamil Deveci and Maruf Boran and Kübra Elif Bahar and Fatma Sarıdağ and Esra Yıldızhan},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15207869},
url = {https://www.mdpi.com/2077-0383/15/20/7869},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Associations of Thrombocytopenia and Subthreshold Platelet Counts with Clinical Outcomes in Intensive Care Patients: A Prospective Cohort Study
AU - Kamil Deveci
AU - Maruf Boran
AU - Kübra Elif Bahar
AU - Fatma Sarıdağ
AU - Esra Yıldızhan
PY - 2026
DA - 2026/10/01
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15207869
UR - https://www.mdpi.com/2077-0383/15/20/7869
AB - Background/Objectives: Thrombocytopenia (TP) is common in critically ill patients, but the significance of its severity, timing, persistence, and admission subthreshold platelet count (PC) remains uncertain. We evaluated these associations with mortality in a medical ICU. Methods: In this prospective cohort study, 280 adults admitted to a tertiary medical ICU (September 2023–August 2024) were followed until ICU discharge or death. TP was defined as a PC < 150 × 109/L, and admission STP as a first ICU PC of 150–199 × 109/L, irrespective of later platelet course. Outcomes included mortality (ICU, hospital, 28-day, 90-day), organ support, and major complications. Results: TP occurred in 118 patients (42.1%), with higher crude mortality at all time points (all p < 0.001). In the lagged time-dependent Cox analysis, ICU-acquired TP was associated with ICU mortality in the minimally adjusted model (HR 1.93, CI 1.12–3.35; p = 0.018) but not after adjustment for invasive MV (aHR 1.31, CI 0.72–2.40; p = 0.372). Admission TP was not significantly associated with ICU mortality in the adjusted model (aHR 1.22, CI 0.74–2.00; p = 0.436). Admission PC showed limited discrimination (AUC 0.583, CI 0.508–0.657). No statistically significant difference was found between admission STP and PC ≥ 200 × 109/L (exploratory comparison, wide CIs). Conclusions: TP was associated with disease severity and worse crude outcomes, but adjusted longitudinal analyses did not establish an independent association with ICU mortality. No statistically significant difference was found for admission STP versus PC ≥ 200 × 109/L in this exploratory comparison; this should not be interpreted as clinical equivalence or as indicating no prognostic value.
SN - 2077-0383
ER -